Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Eppendorf PlateReader AF2200

Published: Friday, June 21, 2013
Last Updated: Friday, June 21, 2013
Bookmark and Share
New PlateReader simplifies set-up and analysis for UV/Vis and fluorescence measurements.

The new Eppendorf PlateReader AF2200 is a highly user-friendly device for quantifying biomolecules, such as nucleic acids and proteins, and for measuring fluorescence-based assays in plate format and is designed to simplify both set-up procedures and data analysis.

The AF2200’s convenient hardware and software solutions are engineered for ease-of-use and include integrated temperature control and plate-shaking options, as well as pre-programmed methods including data analysis and factor-based calculation.

By supporting the instrument with smart accessories, such as the Eppendorf µPlate G0.5 for microvolume applications and pre-configurated filter slides, Eppendorf delivers a complete solution for life scientists across many applications.

It is especially valuable where analysis is in the UV/Vis range and/or involves a wide range of fluorescence dyes.

“The software of the PlateReader AF2200 provides the user with pre-programmed applications and a flexible selection of individual parameters,” says Dr Tanja Musiol, Global Product Manager Detection at Eppendorf AG.

Dr Musiol continued, “It also offers the option to freely program all parameters in order to meet individual requirements. Our pre-configured filter slides are optimized to the pre-programmed methods and are designed to offer the highest flexibility while preventing cross talk. The whole system is developed to simplify set-up procedures and data analysis - making daily lab work easier.”

The broad range of accessories that accompanies the PlateReader AF2200 includes pre-configured filter slides with optimized filter assignment.

A choice of 70 additional filters is also available to enable users to tailor measurements for highly specific applications.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!